Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer
Abstract Background Circulating tumor DNA (ctDNA) detected before surgery disappears after complete surgical resection of the cancer. Residual ctDNA indicates minimal residual disease (MRD), which is a cause of recurrence. The presence of long‐fragment circulating cell‐free DNA (cfDNA) or methylated...
Main Authors: | Kazuhide Ko, Yoshikazu Kananazawa, Takeshi Yamada, Daisuke Kakinuma, Kunihiko Matsuno, Fumihiko Ando, Sho Kuriyama, Akihisa Matsuda, Hiroshi Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3755 |
Similar Items
-
Clinical Applications of Liquid Biopsy in Gastric Cancer
by: Mihaela Chivu-Economescu, et al.
Published: (2021-09-01) -
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis
by: Yunhe Gao, et al.
Published: (2019-11-01) -
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients
by: Luc Cabel, et al.
Published: (2019-03-01) -
The Emerging Role of Liquid Biopsy in Gastric Cancer
by: Csongor György Lengyel, et al.
Published: (2021-05-01) -
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
by: Hariti Saluja, et al.
Published: (2018-07-01)